Birchview Capital, LP
Top Portfolio Positions
69 positions ·
$169,301,473 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| KLAC |
Kla Corp
Technology
|
19,883 | $29,275,928 | 17.29% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
306,268 | $18,575,154 | 10.97% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
1,465,867 | $7,754,436 | 4.58% | |
| LRCX |
Lam Research Corp
Technology
|
36,000 | $7,691,760 | 4.54% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
210,000 | $6,837,600 | 4.04% | |
| OVV |
Ovintiv Inc.
Energy
|
107,500 | $6,381,200 | 3.77% | |
| NTLA |
Intellia Therapeutics, Inc.
Healthcare
|
445,400 | $5,710,028 | 3.37% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
100,000 | $4,820,000 | 2.85% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
625,980 | $4,507,056 | 2.66% | |
| PRTA |
Prothena Corp Public Ltd Co
Healthcare
|
449,019 | $4,364,464 | 2.58% |
Portfolio Trend
25 quarters · across all stocks
Holdings in PHAT
Shares Held
Position Value (USD)
4 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,166,450 | 195,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,235,050 | 195,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,000,450 | 85,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $239,750 | 25,000 | Shares | Sole | 2025-08-14 | |
| No 13F history on record for this holder in this stock. | ||||||